IDOIA
MARTIN GUERRERO
PROFESORADO AGREGADO
![Foto de IDOIA](/img/nophoto.png)
![Foto de Hospital de Cruces](/img/noimage_org.png)
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadoras/es de Hospital de Cruces (21)
2024
-
CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL
International Journal of Molecular Sciences, Vol. 25, Núm. 3
2023
-
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
Acta Neuropathologica, Vol. 145, Núm. 5, pp. 651-666
-
microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma
Scientific reports, Vol. 13, Núm. 1, pp. 12159
2022
-
Identification and Functional Analysis of a Novel CTNNB1 Mutation in Pediatric Medulloblastoma
Cancers, Vol. 14, Núm. 2
2020
-
Role of rs10406069 in miR-5196 in hyperdiploid childhood acute lymphoblastic leukemia
Epigenomics, Vol. 12, Núm. 22, pp. 1949-1955
-
Variability in Cerebrospinal Fluid MicroRNAs Through Life
Molecular Neurobiology, Vol. 57, Núm. 10, pp. 4134-4142
2019
-
Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review
Critical Reviews in Oncology/Hematology, Vol. 139, pp. 7-15
-
Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia
Pharmacogenomics Journal, Vol. 19, Núm. 6, pp. 564-569
2018
-
Involvement of SNPs in miR-3117 and miR-3689d2 in childhood acute lymphoblastic leukemia risk
Oncotarget, Vol. 9, Núm. 33, pp. 22907-22914
-
Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment
Pharmacogenomics, Vol. 19, Núm. 18, pp. 1403-1412
-
Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia
Pharmacogenomics Journal, Vol. 18, Núm. 6, pp. 704-712
-
Pharmacoepigenetics in childhood acute lymphoblastic leukemia: Involvement of miRNA polymorphisms in hepatotoxicity
Epigenomics, Vol. 10, Núm. 4, pp. 409-417
-
Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia
Pharmacogenomics, Vol. 19, Núm. 4, pp. 361-373
2017
2016
-
Lack of association of the CEP72 RS924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population
Pharmacogenetics and Genomics, Vol. 26, Núm. 2, pp. 100-102
-
MIR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia
Pharmacogenetics and Genomics, Vol. 26, Núm. 11, pp. 517-525
-
Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia
Pharmacogenomics, Vol. 17, Núm. 7, pp. 731-741
2014
-
Methylation of the nonhomologous end joining repair pathway genes does not explain the increase of translocations with aging
Age, Vol. 36, Núm. 6
-
Noncoding RNA-related polymorphisms in pediatric acute lymphoblastic leukemia susceptibility
Pediatric Research, Vol. 75, Núm. 6, pp. 767-773
2011
-
Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia
Pediatric Blood and Cancer, Vol. 57, Núm. 4, pp. 612-619